An Oncology biotech pioneering  RAD51 inhibition to treat high replication stress tumors

Satya expands lab infrastructure

Satya is expanding its lab infrastructure and team size at its facilities in Hyderabad, India to add additional discovery programs to the pipeline.

Upon completion, the lab size would double and the company can run up to six discovery programs in parallel.
Scroll to Top